PHARMACOKINETIC PROPERTIES OF ANTIRETROVIRAL DRUGS DURING PREGNANCY

该子项目是利用NIH/NCRR资助的中心赠款提供的资源的许多研究子项目之一。子项目和研究者（PI）可能从另一个NIH来源获得了主要资金，因此可以在其他CRISP条目中表示。所列机构为中心机构，不一定为研究者机构。这项研究的目的是找到怀孕期间治疗感染和保护婴儿所需的HIV药物的正确数量。我们将比较孕妇和非孕妇服用相同药物的艾滋病毒药物水平。此外，脐带血中发现的药物水平将与分娩时血液中的药物水平进行比较。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of the study is to find the correct amount of HIV medicines needed during pregnancy to treat your infection and to protect your baby. We will compare levels of HIV medicines in pregnant women to levels of non-pregnant adults on the same medicines. In addition, the levels of medicine found in blood from the umbilical cord will be compared to the levels of medicine in your blood at the time of delivery.